What Is Wrong at Care.Com After the IPO?
Care.com was supposed to be a great IPO. But on a day that the stock market hit a new high, this stock is trading at a post-IPO low. This is now trading as a…
All Work
Jon C. Ogg
Does a Wider Trade Deficit Even Matter?
ThinkstockThe trade balance has begun to matter again. After all, lower energy imports and higher energy exports have been a game changer in America. That being said, should we be concerned that one month’s…
New Highs for Qualcomm Sure Feel Different 14 Years Later
Qualcomm hit what seemed like new all-time highs on Thursday. The problem is that this has to be compared to the tech bubble days, when valuations were through the roof on anything in technology.
Amgen Faces Cool Reception Over GSK Pact Termination
Amgen submitted an SEC Filing showing that, as of April 1, one of its subsidiaries and a GlaxoSmithKline subsidiary have terminated part and amended part of a collaboration agreement from 2009.
When an Analyst Treats Citigroup the Same as J.P. Morgan
ThinkstockNot all banks are created equally, and not all Wall Street analysts are treating each bank the same. Oppenheimer is treating most of the major money-center banks as though they are all created equally.…
Top Analyst Upgrades and Downgrades: Apple, Intel, Chevron, Exxon, Qualcomm, Citigroup and More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Thursday, April 3, 2014. They include Apple, Intel, Chevron, Exxon, Qualcomm and Citigroup.
Biotech Giants Now Priced Like Old World Drug Stocks
Most investors buying Big Pharma stocks these days are buying them for dividends and somewhat of a defensive position against stock market volatility. Investors who are buying biotechs generally are looking for serious growth.…
What Health Risk in Soda? Coca-Cola Credit Ratings Looking Positive
Coca-Cola is a Dow Jones industrial Average component with shares that have been pressured compared to the broad market. Now we have a positive ratings action from Standard & Poor's.
More Fed Predictions of Late 2015 Rate Hikes
ThinkstockDennis Lockhart, president and chief executive officer of the Federal Reserve Bank of Atlanta, gave a speech on Wednesday to the Greater Miami Chamber of Commerce (obviously in Miami, Fla.). While individual Fed presidents…
Why Western Union and PayPal Better Watch Out for Bitcoin
TheWhyForum.comBitcoin remains a mystery to much of the public, even while it has fought for its life as a currency and method of payment. Now a new angle has surfaced, with Fitch Ratings issuing…
TrimTabs Shows Higher Payrolls Growth Ahead of Labor Department
TrimTabs Investment Research indicates that the U.S. economy added between 195,000 and 225,000 jobs in the month of March. TrimTabs often has been conservative in its payrolls expectations.
Is the High-Frequency Trading Virtu IPO Toast?
ThinkstockVirtu Financial Inc. was supposed to be one of the top ten IPOs of 2014. Now it appears as though the high frequency trading shop, which almost never loses money on a daily basis,…
Six Tech and Communications Buyout Candidates From Oppenheimer
ThinkstockThe analysts at Oppenheimer are making a single huge statement in a new research report. They see more technological change occurring in the next three years than at any point since the late 1990s.…
ADP Foreshadows Strong Payrolls Gain From Labor Department
ThinkstockADP private sector payrolls data was one of the key metrics we were looking for ahead of Friday’s key unemployment and payrolls reports. It is a large gain, but perhaps not quite as robust…
Large Cap Biotechs Trading With Only Big Pharma P/E Ratios
In a new report from RBC, its analysts say that biotech stocks trading at some of the lowest forward multiples in years are very attractive for many investors. Here are the top names rated…
Top Analyst Upgrades and Downgrades: Apollo Education, Ford, GM, Alkermes, Cognizant and More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday, April 2, 2014. They include Apollo Education, Ford, GM, Alkermes and Cognizant Technology.
Can MannKind Shares Double Again on FDA Approval? (Final)
MannKind has a serious victory within its grasp. The company has struggled to get its Afrezza inhalable insulin to market for years, and that dream now seems to be within its grasp.
Vindication for MannKind With FDA Panel Backing
ThinkstockMannKind Corp. (NASDAQ: MNKD)had been trading as though the stock was bracing for an U.S. Food and Drug Administration (FDA) panel decision recommending against the approval of its inhalable insulin called Afrezza. On Tuesday…
Comcast and Time Warner Cable Merger Faces Stock Shock Dilemma
ThinkstockComcast Corp. (NASDAQ: CMCSA) is set to get even larger in cable if it is able to get the deal done with Time Warner Cable Inc. (NYSE: TWC). It has been nearly two months…
Pacific Ethanol Outlook and Update Bring More Hope and Ambition
thinkstockPacific Ethanol, Inc. (NASDAQ: PEIX) came within about 1% of hitting a new 52-week high on Tuesday. The operational update was provided in its 10-K commentary. Pacific Ethanol produced 149.7 million gallons of ethanol…